New York City

Brolucizumab Prevails in Treat-and-Extend Trial of Anti-VEGF Therapy for Eye Disease

Byalexapost

Jul 20, 2022
Brolucizumab Prevails in Treat-and-Extend Trial of Anti-VEGF Therapy for Eye Disease

MedPage Today) — NEW YORK CITY — The monoclonal antibody brolucizumab (Beovu) significantly extended the treatment-free interval without disease activity for neovascular age-related macular degeneration (nAMD), with comparable visual acuity…
Read More

By alexapost

Related Post

New York City

ROH Final Battle 2024 Results: Winners, Live Grades, Reaction and Highlights

Dec 22, 2024 alexapost
New York City

The people who deliver your Amazon packages are striking. Here’s why.

Dec 21, 2024 alexapost
New York City

Brazil’s illegal gold miners carve out new Amazon hotspots in conservation units

Dec 21, 2024 alexapost

You missed

New York City

ROH Final Battle 2024 Results: Winners, Live Grades, Reaction and Highlights

Dec 22, 2024 alexapost
New York City

The people who deliver your Amazon packages are striking. Here’s why.

Dec 21, 2024 alexapost
New York City

Brazil’s illegal gold miners carve out new Amazon hotspots in conservation units

Dec 21, 2024 alexapost
New York City

Former top aide to New York City Mayor Eric Adams accused of bribery, money laundering

Dec 21, 2024 alexapost